NCT04998526

Brief Summary

This study will be conducted to evaluate the effect of local cold application to the nape of the neck on systolic blood pressure, diastolic blood pressure, heart rate, heart rate pressure and headache.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

August 4, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 10, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

August 10, 2021

Status Verified

August 1, 2021

Enrollment Period

7 months

First QC Date

August 4, 2021

Last Update Submit

August 4, 2021

Conditions

Keywords

Cold applicationHeadacheHeart rateNursing

Outcome Measures

Primary Outcomes (1)

  • Blood pressure

    Lowering blood pressure

    90 minute

Study Arms (3)

Experimental group

EXPERIMENTAL

After routine drug treatment is given to hypertension patients, the cold gel pack will be applied to the nape for 3 minutes.

Other: Experimental group

Placebo group

PLACEBO COMPARATOR

After routine drug therapy is given to hypertension patients, the gel pack kept at room temperature will be applied to the nape for 3 minutes.

Other: Placebo group

Control group

NO INTERVENTION

Routine drug treatment will be given to hypertension patients and no application will be made.

Interventions

The cold gel pack will be applied to the nape.

Also known as: Cold application
Experimental group

The gel pack kept at room temperature will be applied to the nape.

Placebo group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • mg sublingual ACE inhibitor given as a treatment protocol,
  • No wound on the nape,
  • Does not develop cold intolerance,
  • Not taking any hypertension medication and pain medication in the last 6 hours,
  • Without heart diseases, peripheral arterial circulation disorders, sensory disorders and edema,
  • Not pregnant,
  • Agreeing to participate in the study,
  • Essential hypertension patients with systolic blood pressure 160 - 179 mmHg, diastolic blood pressure 100 - 109 mmHg.

You may not qualify if:

  • Developing cold intolerance,
  • Changes in the treatment regimen,
  • Panic attack, allergic reaction and any similar situation develops,
  • Those who want to withdraw from the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Van Yüzüncü Yıl University Dursun Odabaş Medical Centre Emergency Service

Van, 65080, Turkey (Türkiye)

Location

MeSH Terms

Conditions

HypertensionHeadache

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • YAVUZ ÜREN, PhD Student

    Ataturk University

    PRINCIPAL INVESTIGATOR
  • EMİNE KIYAK, Prof.Dr.

    Ataturk University

    STUDY CHAIR
  • SEVDEGÜL BİLVANİSİ, Prof.Dr.

    Yuzuncu Yil University

    STUDY CHAIR

Central Study Contacts

YAVUZ ÜREN, PhD Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study, which is planned as a randomized controlled and experimental study, will be conducted with type 2 (systolic blood pressure between 160 and 179 mmHg, diastolic blood pressure between 100 and 109 mmHg) essential hypertension patients who refer to Van Yüzüncü Yıl University Dursun Odabaş Medical Centre Emergency Service. The patients will be distributed as 24 in experimental group, 24 in placebo group and 24 in control group based on block randomization (gender and age) method and a total of 72 patients will be included.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

August 4, 2021

First Posted

August 10, 2021

Study Start

August 1, 2021

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

August 10, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations